Table 4. Table of contigency (portio vaginalis uteri carcinoma in situ).
Test | Disease present (PVU carcinoma in situ) | Disease absent (control group) | Total |
---|---|---|---|
bcl-2 overexpression | 10 (P=0.018) | 2 | 12 |
bcl-2 negative | 12 | 34 | 46 |
Total | 22 | 36 | 58 |
PVU, portio vaginalis uteri.